ELI
Learn

Ditto Bio - Artificial Intelligence and Machine Learning Tool

Artificial Intelligence and Machine Learning · Founded by Dennis Sun & PhD in 2026

Ditto Bio

Ditto Bio

Evolutionary therapies for autoimmune disease

Cost

Paid

Time to value

Requires Expertise

You can use Ditto Bio to discover new drugs for autoimmune diseases by studying parasites, viruses, ticks and worms. The company uses AI to identify proteins from parasites that could calm overactive immune systems. Their research focuses on how parasites naturally redirect immune responses, which could lead to treatments for conditions like rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. They combine experimental biology with computational approaches to run full drug discovery cycles.

What Ditto Bio does

Screen parasite proteins for immune effectsAnalyze host-pathogen interaction dataDesign experiments testing therapeutic candidatesBuild computational models of immune responsesIdentify drug targets from evolutionary biologyTest protein effects on autoimmune conditionsValidate therapeutic candidates in laboratory studiesResearch natural immunomodulatory mechanismsMine therapeutic proteins from parasite genomesStudy host-pathogen immune interactionsIdentify immunomodulatory compounds from natureApply evolutionary biology to drug discoveryTarget hyperactive immune system responsesFocus specifically on autoimmune conditionsCombine wet lab experiments with AI analysisResearch viruses, ticks and worms for drug leads

Frequently asked

Want a tailored answer?

See whether Ditto Bio fits your stack.

Techbible weighs Ditto Bio against what you already pay for, your team shape, and the work that's actually happening. Free to start.

Ditto Bio, drug discovery, autoimmune diseases, parasite biology, AI drug development, immunology, biotechnology, pharmaceutical research, host-pathogen interactions, therapeutic proteins, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, computational biology, bioinformatics, Y Combinator, biotech startup, medical research, evolutionary biology